We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+8.23%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$236M
AUM Growth
-$42.2M
Cap. Flow
-$54M
Cap. Flow %
-22.88%
Top 10 Hldgs %
50.67%
Holding
47
New
9
Increased
8
Reduced
13
Closed
12

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$29.5M
2
ABT icon
Abbott
ABT
+$6.58M
3
MDT icon
Medtronic
MDT
+$5.05M
4
RVTY icon
Revvity
RVTY
+$4.7M
5
ZBH icon
Zimmer Biomet
ZBH
+$4.37M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$8.15M
2
TMO icon
Thermo Fisher Scientific
TMO
+$7.74M
3
BIIB icon
Biogen
BIIB
+$6.96M
4
RMD icon
ResMed
RMD
+$5.74M
5
EW icon
Edwards Lifesciences
EW
+$5.54M

Sector Composition

Rank Sector Weight
1 Healthcare 86.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.3B
$29.6M 12.55%
+300,000
New +$29.5M
LLY icon
2
Eli Lilly
LLY
$1.06T
$12.8M 5.44%
14,500
-500
-3% -$450K
THC icon
3
Tenet Healthcare
THC
$21.1B
$10.8M 4.57%
65,000
-5,000
-7% -$756K
NVO
4
Novo Nordisk
NVO
$209B
$10.7M 4.54%
90,000
– –
UHS icon
5
Universal Health Services
UHS
$10.5B
$10.3M 4.36%
45,000
+5,000
+13% +$1.08M
MCK icon
6
McKesson
MCK
$101B
$9.89M 4.19%
20,000
+2,000
+11% +$1.11M
SYK icon
7
Stryker
SYK
$130B
$9.75M 4.13%
27,000
+2,000
+8% +$690K
BSX icon
8
Boston Scientific
BSX
$71.5B
$8.8M 3.73%
105,000
-10,000
-9% -$788K
ISRG icon
9
Intuitive Surgical
ISRG
$134B
$8.6M 3.64%
17,500
– –
DHR icon
10
Danaher
DHR
$144B
$8.34M 3.53%
30,000
– –
HCA icon
11
HCA Healthcare
HCA
$89.5B
$8.13M 3.44%
20,000
-5,000
-20% -$1.83M
SGRY icon
12
Surgery Partners
SGRY
$2.03B
$7.42M 3.14%
230,000
-20,000
-8% -$591K
ACHC icon
13
Acadia Healthcare
ACHC
$2.94B
$7.29M 3.09%
115,000
+34,997
+44% +$2.53M
ABT icon
14
Abbott
ABT
$187B
$6.84M 2.9%
+60,000
New +$6.58M
AVTR icon
15
Avantor
AVTR
$9.19B
$6.47M 2.74%
250,000
– –
BDX icon
16
Becton Dickinson
BDX
$48.2B
$6.03M 2.55%
25,000
– –
BAX icon
17
Baxter International
BAX
$14.2B
$5.7M 2.41%
150,000
+50,000
+50% +$1.84M
COR icon
18
Cencora
COR
$61.2B
$5.63M 2.38%
25,000
-1,000
-4% -$232K
MDT icon
19
Medtronic
MDT
$112B
$5.4M 2.29%
+60,000
New +$5.05M
RVTY icon
20
Revvity
RVTY
$12.8B
$5.11M 2.16%
+40,000
New +$4.7M
WST icon
21
West Pharmaceutical
WST
$24.9B
$5.1M 2.16%
17,000
+4,000
+31% +$1.22M
CAH icon
22
Cardinal Health
CAH
$55.4B
$4.97M 2.11%
45,000
-15,000
-25% -$1.57M
SEM
23
DELISTED
Select Medical
SEM
$4.88M 2.07%
259,840
-9,280
-3% -$178K
EHC icon
24
Encompass Health
EHC
$12.4B
$4.83M 2.05%
50,000
-5,000
-9% -$449K
VRTX icon
25
Vertex Pharmaceuticals
VRTX
$126B
$4.65M 1.97%
10,000
-5,000
-33% -$2.4M
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
A
AFBI Miami Beach, Florida $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return

Sivik Global Healthcare's Q3 2024 Portfolio in Review

As of Q3 2024, Sivik Global Healthcare held 47 positions worth $236M, down 15% from $278M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sivik Global Healthcare withdrew a net $54M in Q3 2024, closing 12 positions and reducing 13 holdings. Its most notable exit was Merck, an estimated $8.15M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, up from 80% a quarter earlier.

Against the trend, Sivik Global Healthcare opened a new position in State Street SPDR S&P Biotech ETF worth $29.6M.

  • Sivik Global Healthcare's largest Q3 2024 buy was State Street SPDR S&P Biotech ETF: 300,000 shares worth $29.6M.
  • Sivik Global Healthcare added most to Acadia Healthcare in Q3 2024, an estimated $2.53M increase.
  • Sivik Global Healthcare's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $2.4M.
  • Sivik Global Healthcare fully exited Merck in Q3 2024, selling an estimated $8.15M.
  • Sivik Global Healthcare's ten largest holdings make up 51% of its $236M portfolio in Q3 2024.
  • Sivik Global Healthcare opened 9 new positions and closed 12 in Q3 2024.
  • Sivik Global Healthcare's portfolio value fell 15% quarter-over-quarter to $236M.

Based on Sivik Global Healthcare's 13F filing for Q3 2024, filed 6 Nov 2024.